199 related articles for article (PubMed ID: 24467620)
1. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
[TBL] [Abstract][Full Text] [Related]
2. Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
Yu A; Wang H; Wang J; Cao F; Gao Y; Cui J; Zhai G
J Pharm Sci; 2011 Mar; 100(3):933-41. PubMed ID: 20862776
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of puerarin using microemulsion vehicle.
Wu H; Lu C; Zhou A; Min Z; Zhang Y
Drug Dev Ind Pharm; 2009 Feb; 35(2):138-44. PubMed ID: 19040180
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs].
Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF
Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564
[TBL] [Abstract][Full Text] [Related]
7. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations.
Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX
Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046
[TBL] [Abstract][Full Text] [Related]
8. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.
Zhang Y; Wang R; Wu J; Shen Q
Int J Pharm; 2012 May; 427(2):337-44. PubMed ID: 22366381
[TBL] [Abstract][Full Text] [Related]
9. Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.
Paliwal R; Paliwal SR; Agrawal GP; Vyas SP
Int J Pharm; 2012 Jan; 422(1-2):179-84. PubMed ID: 22079712
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of puerarin liposome and its oral absorption in rat].
Gu YZ; Zhou W; Zhai GX
Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848
[TBL] [Abstract][Full Text] [Related]
11. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
Quan DQ; Xu GX
Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
[TBL] [Abstract][Full Text] [Related]
12. N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin.
Chen H; Wu J; Sun M; Guo C; Yu A; Cao F; Zhao L; Tan Q; Zhai G
J Liposome Res; 2012 Jun; 22(2):100-9. PubMed ID: 22007962
[TBL] [Abstract][Full Text] [Related]
13. Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle.
Hu L; Jia Y; Niu F; Jia Z; Yang X; Jiao K
J Agric Food Chem; 2012 Jul; 60(29):7137-41. PubMed ID: 22587560
[TBL] [Abstract][Full Text] [Related]
14. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
15. Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile.
Li W; Wu J; Zhang J; Wang J; Xiang D; Luo S; Li J; Liu X
Drug Deliv; 2018 Nov; 25(1):827-837. PubMed ID: 29587545
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion.
Yue PF; Yuan HL; Yang M; You RH; Cong LB; Zhu J; Wang Q; Zhu WF; Xiao XH
PDA J Pharm Sci Technol; 2008; 62(1):32-45. PubMed ID: 18402366
[TBL] [Abstract][Full Text] [Related]
17. Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro.
Chen WL; Yuan ZQ; Liu Y; Yang SD; Zhang CG; Li JZ; Zhu WJ; Li F; Zhou XF; Lin YM; Zhang XN
Int J Nanomedicine; 2016; 11():325-36. PubMed ID: 26855571
[TBL] [Abstract][Full Text] [Related]
18. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Ramalingam P; Ko YT
Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233
[TBL] [Abstract][Full Text] [Related]
19. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
[TBL] [Abstract][Full Text] [Related]
20. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
